Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung

Vol. 206, No. 4, April 13, 2009. Pages 937–952.

A description of the RELM-α–deficient mice used in this study also appeared in a paper published in December, 2008 in the Journal of Allergy and Clinical Immunology (Munitz et al. J. Allergy Clin. Immunol. 2008. 122:1200–1207). The Munitz et al. paper was cited in the Discussion (reference 53), but this citation was inadvertently omitted in the Results section.